Agenus INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ

23 Jan 2026

AGEN

SCHEDULE: Zydus Acquires 5.9% Stake in Agenus, Forges Strategic Alliance

Zydus Lifesciences and its affiliates have acquired a 5.9% stake in AGENUS INC for $16 million, initiating a strategic collaboration and licensing deal.